logo
#

Latest news with #TRX

Tron's TRX Faces Rising Risk of Bearish Momentum After High-Volume Drop to 27 Cents
Tron's TRX Faces Rising Risk of Bearish Momentum After High-Volume Drop to 27 Cents

Yahoo

time3 days ago

  • Business
  • Yahoo

Tron's TRX Faces Rising Risk of Bearish Momentum After High-Volume Drop to 27 Cents

Tron's native token, TRX, faced intense selling pressure in the past 24 hours, marking a price from 27.7 cents to 27 cents. The high-volume decline happened alongside turbulence in the broader market influenced by geopolitical tensions and evolving investor sentiment. These macroeconomic factors compound the challenges already presented by high trading volumes. However, the final hour of analysis revealed some market resilience, where TRX slightly recovered from a dip below 27 cents. The 24-hour price drop from $0.277 to $0.270, with a closing price of $0.269, was accompanied by significant volume spikes, reaching 156.716 million, indicating selling pressure. Price volatility between a high of $0.278 and a low of $0.268 was observed. High trading volume points to potential further downward pressure on TRX prices. The quick rebound from under $0.27, coupled with a continued trading interest, suggests a critical support level that may prevent further declines. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Tron Price Prediction - What could affect TRX's future price?
Tron Price Prediction - What could affect TRX's future price?

Yahoo

time5 days ago

  • Business
  • Yahoo

Tron Price Prediction - What could affect TRX's future price?

TRON price prediction: TRON's price could rise if Bitcoin rallies and stablecoin dominance grows, but faces downside risks from whale concentration and regulatory uncertainty. - Bitcoin correlation (0.88) may amplify gains if BTC resumes uptrend. - USDT dominance ($77.7B on TRON) drives utility but invites regulatory scrutiny. - Whales control 72% of supply, raising volatility risks. TRON now processes $611B monthly USDT transfers, surpassing Ethereum and cementing its role as the leading stablecoin settlement layer. This dominance attracts liquidity but exposes TRX to regulatory risks, especially as the SEC prepares a DeFi policy roundtable in June 2025. TRON's 2.4M daily active addresses outpace Ethereum and Base, signaling robust adoption. However, competition from Ethereum's ETF momentum and Solana's low-fee stablecoin growth could pressure TRX's market share. Key levels: Immediate resistance at $0.28 (rejected twice in May 2025). A breakout could target $0.30–$0.38. Support sits at $0.26 (50-day SMA) and $0.243 (swing low). Momentum: RSI (60.77) and MACD (-0.00039) suggest neutral-to-bearish short-term bias. A bullish reversal requires closing above $0.275 (200-day EMA). Derivative markets show balanced open interest ($220M–$240M), with no extreme long/short skew, reducing liquidation cascade risks. The SEC's June 9 'DeFi and the American Spirit' roundtable could clarify rules for protocols like TRON. A hostile stance might dampen sentiment, while clear guidelines could legitimize its $5.5B DeFi ecosystem. Bitcoin ETF flows and Fed rate decisions will also influence TRX's correlation-driven moves. TRX's price hinges on Bitcoin's trajectory, stablecoin adoption trends, and regulatory clarity. Watch for a decisive break above $0.28 with volume, or a drop below $0.26 signaling bearish momentum. What catalyst could decouple TRX from Bitcoin's price action? TRON price prediction: TRON (TRX) sentiment is bullish among traders and analysts, driven by surging USDT adoption, strong Bitcoin correlation, and strategic partnerships, though regulatory risks and technical resistance remain key watchpoints. - TRX now leads Ethereum in USDT transactions ($611B monthly volume). - TRX-BTC correlation (0.88) sparks 4x price surge predictions if Bitcoin rallies. - Partnerships (Rumble Cloud, MoonPay) boost infrastructure and U.S. access. - Technical analysis highlights bullish patterns but warns of resistance at $0.28. Bullish sentiment dominates (61/100 on CMC Fear & Greed Index) due to:- USDT dominance: TRON processed $611B in USDT transfers in May 2025, surpassing Ethereum's volume.- BTC correlation: Analysts like Carmelo Alemán note TRX's 0.88 correlation with Bitcoin, suggesting amplified gains if BTC rallies.- Bearish risks include SEC scrutiny of DeFi (June 9 roundtable) and whale dominance (72% supply held by large wallets). Stablecoin utility: TRON hosts $77.7B in USDT, positioning it as a global payments rail, especially in emerging markets. Technical targets: Traders eye $0.326–$0.4336 if TRX breaks $0.28 resistance, but warn of sell pressure near $0.276–$0.28. Regulatory friction: Mixed reactions to TRON's U.S. expansion via MoonPay and SEC's DeFi dialogue. X (Twitter): Focus on metrics (2.4M daily active addresses) and partnerships. Justin Sun's 'TRX=BTC' posts drove engagement. Telegram/TradingView: Technical traders debate short-term consolidation vs. breakout potential. Reddit: Skepticism persists around centralization (72% whale holdings) and past vulnerabilities (2024 multisig patch). TRON's bullish case hinges on stablecoin dominance and Bitcoin's momentum, but technical resistance and regulatory uncertainty could cap near-term gains. Will TRX's USDT dominance translate into sustained price appreciation, or will reliance on Bitcoin's trend leave it vulnerable to broader market swings? To get the latest update on TRX, visit our Tron currency page. Content created: 30th May 2025 Disclaimer: Content generated by CMC AI. CMC AI can make mistakes, please DYOR. Not financial advice. Sign in to access your portfolio

Tron's TRX Faces Rising Risk of Bearish Momentum After High-Volume Drop to 27 Cents
Tron's TRX Faces Rising Risk of Bearish Momentum After High-Volume Drop to 27 Cents

Yahoo

time6 days ago

  • Business
  • Yahoo

Tron's TRX Faces Rising Risk of Bearish Momentum After High-Volume Drop to 27 Cents

Tron's native token, TRX, faced intense selling pressure in the past 24 hours, marking a price from 27.7 cents to 27 cents. The high-volume decline happened alongside turbulence in the broader market influenced by geopolitical tensions and evolving investor sentiment. These macroeconomic factors compound the challenges already presented by high trading volumes. However, the final hour of analysis revealed some market resilience, where TRX slightly recovered from a dip below 27 cents. The 24-hour price drop from $0.277 to $0.270, with a closing price of $0.269, was accompanied by significant volume spikes, reaching 156.716 million, indicating selling pressure. Price volatility between a high of $0.278 and a low of $0.268 was observed. High trading volume points to potential further downward pressure on TRX prices. The quick rebound from under $0.27, coupled with a continued trading interest, suggests a critical support level that may prevent further declines. Sign in to access your portfolio

TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy
TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

Yahoo

time6 days ago

  • Business
  • Yahoo

TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company" or 'TRX'), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ('Ucare'), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ('VitaCare') have entered into a share exchange agreement (the 'Agreement') with certain shareholders (the 'Sellers') of Ucare and other parties. Under the Agreement, the Sellers will receive 101,486,575 newly-issued class A ordinary shares ('Shares') of TRX, each with a par value of US$0.025. The number of Shares is calculated based on the weighted average closing price of TRX's Class A ordinary shares over the three months preceding the Agreement, at a per-share price of US$1.478. The Shares will represent approximately 91.75% of the Company's total issued and outstanding Class A ordinary shares and approximately 13.70% of its total voting power upon closing, which is subject to customary conditions. Ucare develops innovative healthcare solutions that enable providers, payers, and institutions to reduce fraud, abuse, waste, and administrative costs. Powered by the largest hospital database, Ucare's cloud-based generative AI platform continuously refines disease models by integrating real-world data, the latest medical guidelines, and real-time intelligence. Ucare's vision is to ease the burden on patients, expand coverage, and ultimately improve access to healthcare for everyone. It currently serves over 4,000 hospitals and has contributed an estimated US$6.82 billion reduction in avoidable healthcare expenditures as of December 2024. For the fiscal year ended October 31, 2024, Ucare reported a net profit of US$0.6 million on revenues of US$5.4 million. This acquisition comes at a time when China's health insurance market is rapidly expanding to complement national health coverage reforms. By integrating Ucare's AI-driven data analytics, institutional channels, and clinical treatment guidance tools, TRX aims to build differentiated health insurance products, strengthen their distribution within hospital systems, and accelerate its transition into a data-powered, platform-based insurance service provider. The transaction is expected to close on or about July 2025. Shares issued to the Sellers will be held in escrow and released based on Ucare achieving a cumulative revenue target of at least RMB150 million over the three years following closing. Post-transaction, Ucare will operate as a wholly-owned subsidiary of VitaCare. Key Ucare management, including Chief Executive Officer Mr. Wei Zhu, will remain in their roles to drive continuity and growth. Mr. Wei Zhu, Chief Executive Officer of Ucare, stated, 'We are excited to join forces with TRX in a transaction that validates our mission and achievements. Over the years, we've built China's leading hospital management platform, powered by proprietary AI algorithms and a deep understanding of healthcare system dynamics. TRX's platform, capital access, and industry network will empower us to scale R&D, integrate the latest generative AI into clinical pathways, and expand our offerings from medical institutions to insurance companies. This marks a pivotal moment in building a unified ecosystem that brings hospitals, insurers, and patients closer together for more efficient, transparent healthcare.' Ms. Sheng Xu, Director, Chairwoman and Chief Executive Officer of TRX, commented, 'This Agreement with Ucare represents a critical acquisition that expands our business channels by adding health insurance offerings that complement our property insurance products. With its unique positioning and first-mover advantage as the sole provider of cloud-based AI solutions for health insurance risk management, Ucare gives us privileged access to healthcare data, decision-makers, and patient journeys. This will significantly enhance our ability to design tailored insurance products,recommend solutions, streamline claims and diversify revenues. We view Ucare not only as a growth engine but as a strategic hub that bridges insurance services with healthcare delivery—an integration we believe will define the next decade of our industry.' About TIAN RUIXIANG Holdings LtdTIAN RUIXIANG Holdings Ltd, headquartered in Beijing, China, is an insurance broker operating in China through its China-based variable interest entity. It distributes a wide range of insurance products, which are categorized into two major groups: (1) property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and (2) other types of insurance, such as health insurance, life insurance, and other miscellaneous insurance. About Ucare Inc. develops innovative healthcare solutions that enable providers, payers, and institutions to reduce fraud, abuse, waste, and administrative costs. Powered by the largest hospital database, Ucare's cloud-based generative AI platform continuously refines disease models by integrating real-world data, the latest medical guidelines, and real-time intelligence. Ucare's vision is to ease the burden on patients, expand coverage, and ultimately improve access to healthcare for everyone. Forward-Looking StatementsCertain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review risk factors that may affect its future results in the Company's registration statement and in its other filings with the U.S. Securities and Exchange Commission. For investor and media enquiries, please contact:TIAN RUIXIANG Holdings LtdInvestor Relations DepartmentEmail: ir@ Water Tower ResearchFeifei ShenEmail: feifei@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Drones are forcing the Army to rethink its robotic combat vehicles. See the revolutionary prototypes.
Drones are forcing the Army to rethink its robotic combat vehicles. See the revolutionary prototypes.

Yahoo

time27-05-2025

  • Business
  • Yahoo

Drones are forcing the Army to rethink its robotic combat vehicles. See the revolutionary prototypes.

The US Army's Robotic Combat Vehicles face uncertainty due to shifting Pentagon priorities. The RCV concept is "incredibly invaluable" but vulnerable to cheap drone attacks, officials say. Four prototypes were developed as part of the Army's future plans for ground robotic systems. Robotic Combat Vehicles were billed as the Army's future frontline — uncrewed, unstoppable, and a revolution for ground warfare. But the future of autonomous light tanks now hangs in the balance as the Army reassesses whether combat vehicles that cost millions of dollars are too vulnerable to swarms of cheap drones. The Army had already begun testing four RCV prototypes when it decided to reevaluate its vision for autonomous ground warfare — Textron's Ripsaw M3, General Dynamics Land Systems' TRX, McQ's WOLF-X, and Oshkosh Defense's RCV. "Here's what we believe is true of today, RCV will stop development," Army Maj. Gen. Glenn Dean wrote in an internal memo sent May 1, per Breaking Defense. "The future of the robotic software program is unknown." Robotic Combat Vehicles Launched in 2019, the RCV program aimed to integrate autonomous and remotely operated capabilities into the Army's ground systems for future combat. The Army initially planned to develop three RCV versions — an expendable light variant, a durable medium variant, and a lethal heavy variant capable of defeating "all known enemy armored vehicles." The Army later deferred development of the medium and heavy variants to focus on just the RCV-L in August 2023. Four companies delivered RCV prototypes to the Army to be selected as "the best of breed" for eventual production. The Army was reportedly expected to award the RCV contract in March 2025, just weeks before Defense Secretary Pete Hegseth issued a directive to transform the service into "a leaner, more lethal force." Secretary of the Army Daniel Driscoll said the RCV concept is "incredibly important," but recognized that "we keep creating and purchasing these exquisite machines that very cheap drones can take out." In a May 1 memo, Army officials detailed plans to implement the transformation "by infusing technology, cutting obsolete systems, and reducing overhead to defeat any adversary on an ever-changing battlefield." Textron Ripsaw M3 Developed by Texas-based defense tech company Textron Systems, the Ripsaw M3 is an uncrewed ground vehicle designed to adapt to mission-specific capabilities, including reconnaissance, surveillance, target acquisition, and direct combat support. Equipped with a hybrid-electric powertrain system, the Ripsaw M3 can reach speeds of over 30 miles per hour with a range of 180 miles. The 18,000-pound RCV has a modular open flat deck spanning 63 square feet and a payload capacity of 5,000 pounds. In early March, multiple outlets reported that Textron Systems was awarded the contract to develop the Army's first RCV, but the service didn't officially confirm the selection. Textron also won the prototyping contract for the RCV-M before the Army solely focused on developing the RCV-L. General Dynamics Land Systems TRX In October, General Dynamics Land Systems delivered an updated version of its Tracked Robot 10-ton (TRX) robotic combat vehicle to the Army for consideration. Originally under consideration to be the RCV-M, the 5-ton UGV can accommodate various payloads weighing over 11,000 pounds, including short-range air defense. It can be remotely controlled or operate with full or semi-autonomy. "The TRX offers an innovative solution for some of the Army's force structure challenges," Scott Taylor, US business development director at GDLS, told Breaking Defense in March 2023, "but also, and more importantly, to address many of the dirty, dull and dangerous missions with a innovative multi-payload capable RCV." McQ WOLF-X With Virginia-based defense tech company McQ as the prime contractor, the WOLF-X prototype was developed in collaboration with HDT Global and BAE Systems. The 8×8 wheeled vehicle is powered by a hybrid diesel/electric powertrain and suspension system designed to adapt to challenging terrains. Purpose-built for the Army's RCV competition, the WOLF-X can be modified to carry an MK44 30mm chain gun and enhanced armor, but can fit inside a CH-47D Chinook heavy-lift helicopter in its base configuration. Oshkosh Defense RCV Wisconsin-based contractor Oshkosh Defense designed its RCV "as a "soldier-centered, purpose-built solution" for a modern battlefield, Pat Williams, Oshkosh Defense chief programs officer, said in a statement. Acting as a scout and escort in a crewed mechanized fleet, the tracked autonomous vehicle features a range of capabilities including electronic warfare, troop support, and counter-drone defense. The modular RCV can accommodate various payloads and advanced weapon systems, from small arms to large caliber cannons. Preparing for a drone war While the RCV program was not explicitly mentioned as one of the Army's "obsolete programs," Driscoll said, after putting the RCV concept to the test, the system proved to be "incredibly valuable, but the actual cost ratio just didn't work." "What we've seen, and this has been seen all over the world, is we keep creating and purchasing these exquisite machines that very cheap drones can take out," Driscoll said during a May 6 episode of the War on the Rocks podcast. He added, "We are the wealthiest nation, perhaps in the history of the world, but even we can't sustain a couple-million-dollar piece of equipment that can be taken out with an $800 drone and munition." Army Chief of Staff Gen. Randy George said during the podcast that changes are on the horizon, from what military assets the Army plans to invest in, like long-range missiles, to how the service itself is organized. Though the RCV program is in limbo, George added that the service isn't entirely abandoning autonomous systems but is instead considering the "cost curve for us." "If modern technology can give you something that is a 10th of the cost, a 20th of the cost, we shouldn't be locked into buying something that is terribly expensive," George said. Read the original article on Business Insider

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store